Matches in SemOpenAlex for { <https://semopenalex.org/work/W2017455957> ?p ?o ?g. }
Showing items 1 to 88 of
88
with 100 items per page.
- W2017455957 endingPage "10" @default.
- W2017455957 startingPage "1" @default.
- W2017455957 abstract "Calculation of protective or therapeutic indices is widely used in primary and secondary screening for drugs with selective anticonvulsant activity. The protective index is the median minimal 'neurotoxic' dose, TD50, divided by median effective dose, ED50. TD50s are usually determined by tests, such as the rotarod test or the chimney test, for quantification of 'minimal neurological deficit', such as motor impairment, while median effective doses are commonly determined in the maximal electroshock seizure (MES) test or the s.c. pentylenetetrazol (PTZ) seizure test in mice or rats. For antiepileptic drug development, it has been proposed previously that only compounds with an estimated protective index of at least 5 should proceed to further evaluation. However, various technical, biological and pharmacological factors can influence anticonvulsant or 'neurotoxic' potencies and thereby protective indices. In order to reevaluate the value of protective indexes in the prediction of drugs with selective anticonvulsant action, protective indices were determined for various clinically used antiepileptic drugs in standardized seizure tests, i.e. MES and s.c. PTZ tests in mice and rats, as well as in seizure threshold tests. For most drugs, similar TD50s were determined in the rotarod and chimney test. When protective indices were calculated for the different seizure models, only few drugs reached an index of 5 (some not even reaching an index of 2) in the traditional MES or s.c. PTZ tests in mice and rats. In contrast, using anticonvulsant doses determined by seizure threshold tests, the 5 primary drugs against generalized tonic-clonic seizures, i.e., carbamazepine, phenytoin, phenobarbital, primidone and valproate, had indices of more than 5 in the MES threshold model, while drugs with efficacy against absence and myoclonic seizures, i.e., valproate, ethosuximide and the benzodiazepines, had protective indices of at least 5 in the i.v. PTZ seizure threshold model. The data substantiate that valuable information can be obtained by estimation of protective indices. However, in order to minimize the possibility that an interesting new anticonvulsant compound is overlooked during primary or secondary screening, a protective index of 2 should be considered sufficient in case of traditional MES or s.c. PTZ models with fixed seizure stimulus. Alternatively, seizure threshold models could be used for calculation of protective indices in order to avoid underestimation of anticonvulsant selectivity of test compounds." @default.
- W2017455957 created "2016-06-24" @default.
- W2017455957 creator A5010235451 @default.
- W2017455957 creator A5026744991 @default.
- W2017455957 date "1991-05-01" @default.
- W2017455957 modified "2023-09-23" @default.
- W2017455957 title "The role of technical, biological and pharmacological factors in the laboratory evaluation of anticonvulsant drugs. IV. Protective indices" @default.
- W2017455957 cites W1973320363 @default.
- W2017455957 cites W1981918700 @default.
- W2017455957 cites W1988434605 @default.
- W2017455957 cites W2013231326 @default.
- W2017455957 cites W2018021139 @default.
- W2017455957 cites W2023292449 @default.
- W2017455957 cites W2025089151 @default.
- W2017455957 cites W2029462182 @default.
- W2017455957 cites W2037997999 @default.
- W2017455957 cites W2055806250 @default.
- W2017455957 cites W2060204201 @default.
- W2017455957 cites W2067686370 @default.
- W2017455957 cites W2073940547 @default.
- W2017455957 cites W2155633484 @default.
- W2017455957 doi "https://doi.org/10.1016/0920-1211(91)90041-d" @default.
- W2017455957 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/1884714" @default.
- W2017455957 hasPublicationYear "1991" @default.
- W2017455957 type Work @default.
- W2017455957 sameAs 2017455957 @default.
- W2017455957 citedByCount "150" @default.
- W2017455957 countsByYear W20174559572012 @default.
- W2017455957 countsByYear W20174559572013 @default.
- W2017455957 countsByYear W20174559572014 @default.
- W2017455957 countsByYear W20174559572015 @default.
- W2017455957 countsByYear W20174559572016 @default.
- W2017455957 countsByYear W20174559572017 @default.
- W2017455957 countsByYear W20174559572018 @default.
- W2017455957 countsByYear W20174559572019 @default.
- W2017455957 countsByYear W20174559572020 @default.
- W2017455957 countsByYear W20174559572021 @default.
- W2017455957 countsByYear W20174559572022 @default.
- W2017455957 countsByYear W20174559572023 @default.
- W2017455957 crossrefType "journal-article" @default.
- W2017455957 hasAuthorship W2017455957A5010235451 @default.
- W2017455957 hasAuthorship W2017455957A5026744991 @default.
- W2017455957 hasConcept C118552586 @default.
- W2017455957 hasConcept C19831878 @default.
- W2017455957 hasConcept C2775858608 @default.
- W2017455957 hasConcept C2776819090 @default.
- W2017455957 hasConcept C2777496795 @default.
- W2017455957 hasConcept C2778186239 @default.
- W2017455957 hasConcept C2778337148 @default.
- W2017455957 hasConcept C2778460930 @default.
- W2017455957 hasConcept C2779253243 @default.
- W2017455957 hasConcept C2780035454 @default.
- W2017455957 hasConcept C71924100 @default.
- W2017455957 hasConcept C98274493 @default.
- W2017455957 hasConceptScore W2017455957C118552586 @default.
- W2017455957 hasConceptScore W2017455957C19831878 @default.
- W2017455957 hasConceptScore W2017455957C2775858608 @default.
- W2017455957 hasConceptScore W2017455957C2776819090 @default.
- W2017455957 hasConceptScore W2017455957C2777496795 @default.
- W2017455957 hasConceptScore W2017455957C2778186239 @default.
- W2017455957 hasConceptScore W2017455957C2778337148 @default.
- W2017455957 hasConceptScore W2017455957C2778460930 @default.
- W2017455957 hasConceptScore W2017455957C2779253243 @default.
- W2017455957 hasConceptScore W2017455957C2780035454 @default.
- W2017455957 hasConceptScore W2017455957C71924100 @default.
- W2017455957 hasConceptScore W2017455957C98274493 @default.
- W2017455957 hasIssue "1" @default.
- W2017455957 hasLocation W20174559571 @default.
- W2017455957 hasLocation W20174559572 @default.
- W2017455957 hasOpenAccess W2017455957 @default.
- W2017455957 hasPrimaryLocation W20174559571 @default.
- W2017455957 hasRelatedWork W1980918385 @default.
- W2017455957 hasRelatedWork W1994671581 @default.
- W2017455957 hasRelatedWork W2017455957 @default.
- W2017455957 hasRelatedWork W2021565085 @default.
- W2017455957 hasRelatedWork W2061082755 @default.
- W2017455957 hasRelatedWork W2068466693 @default.
- W2017455957 hasRelatedWork W2073940547 @default.
- W2017455957 hasRelatedWork W2277643767 @default.
- W2017455957 hasRelatedWork W2952663510 @default.
- W2017455957 hasRelatedWork W2968606710 @default.
- W2017455957 hasVolume "9" @default.
- W2017455957 isParatext "false" @default.
- W2017455957 isRetracted "false" @default.
- W2017455957 magId "2017455957" @default.
- W2017455957 workType "article" @default.